Clinical Trial Update: AMENO-2: Aprepitant Plus Palonosetron Versus Granisetron in the Prevention of Nausea and the Emesis Induced by Chemotherapy in Patients Treated With Haematopoietic Progenitors [Phase 4]

View source ↗

Summary

Phase 4 study comparing aprepitant plus palonosetron versus granisetron for the prevention of chemotherapy-induced nausea and vomiting in patients receiving hem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma

Drugs mentioned

• Aprepitant (aprepitant)
• Granisetron (granisetron)
• Palonosetron (palonosetron)

Snippet

Sponsor: PETHEMA Foundation | Conditions: Leukemia, Lymphoma | Phase 4 | Status: COMPLETED